24 HR Emsam 0.25 MG/HR Transdermal System
- RxCUI
- 865208
- RxNorm name
- 24 HR Emsam 0.25 MG/HR Transdermal System
- Display name
- 24 HR Emsam 0.25 MG/HR Transdermal System
- Full name
- 24 HR Emsam 0.25 MG/HR Transdermal System
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:18
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EMSAM | SELEGILINE | Viatris Specialty LLC | b891bd9f-fdb8-4862-89c5-ecdd700398a3 | 2020-05-15 | Boxed warning, Warnings, Adverse reactions | 865208 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b891bd9f-fdb8-4862-89c5-ecdd700398a3 | EMSAM 6 MG/Day 24HR Transdermal System [PSN] · 24 HR selegiline 0.25 MG/HR Transdermal System [Emsam] [SBD] · 24 HR Emsam 0.25 MG/HR Transdermal System [SY] · Emsam 6 MG per 24 HR Transdermal Patch [SY] · EMSAM 6 MG/Day 24HR Transdermal System [SY] | 5 | 17 | These highlights do not include all the information needed to use EMSAM safely and effectively. See full prescribing information for EMSAM. EMSAM ® (selegiline transdermal system) Initial U.S. Approval: 2006 | 20200515 |